Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

CellCarta and Leica Biosystems have announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

Neuland reports record quarterly revenue of $83M* driven by commercial NCE projects

Quarterly revenue growth up 135% year-on-year, with total revenues passing ₹2000 crore for the first time

ProPharma Appoints Adrian Pencak as Chief Commercial Officer

Life Sciences Industry Veteran Appointed to Lead Global Commercial Organization

University of Manchester techbio spin-out secures £5 million to deploy quantum physics, AI modelling, and highly automated labs to power next gen enzyme engineering

£5 million seed funding round by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone Company uses quantum physics, AI modelling and deeply integrated laboratory automation and robotics in a closed loop system to engineer enzymes, transforming their performance for industries including pharmaceutical manufacturing, personal care and sustainable chemical production Work with a Fortune 500 personal care company delivering over 670x improvements in enzyme performance Guy Levy-Yurista joins as CEO to spearhead growth in closed loop AI-guided enzyme engineering

Yourgene Health Launches Insight DPYD Assay

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

Cytiva introduces next-generation Biacore 8 series SPR systems for faster, more confident drug discovery

Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology

Atrandi announced the appointments of Sam Ropp as Chief Commercial Officer and Susan Tousi as Chairman of the Board. These additions strengthen Atrandi’s leadership team as the company accelerates global adoption of its single-cell multiomic SPC technology.

NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms

Epigenica AB has announced an agreement with the National Genomics Infrastructure, one of the largest technical platforms at SciLifeLab.

Ladder Bio Appoints Jay Fine, PhD and John Prufeta to Board of Directors

Ladder Bio, Inc., a structure-guided biotechnology company developing Spiroligomers™, a new class of chemical matter as medicines, today announced the appointments of Jay Fine, PhD, and John Prufeta to its Board of Directors.

Medix Biochemica Announces $5 Million Investment to Expand Recombinant Antigen Capabilities

Medix Biochemica has announced a Board-approved $5 million investment to expand its recombinant antigen and cell culture technology capabilities across its Espoo, Finland and St. Louis, Missouri facilities.

Cytiva’s ELEVECTA transient cell line receives advanced manufacturing technology (AMT) designation from the FDA

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Qureight and Mediar Therapeutics (Mediar) today announced Qureight’s AI-powered 3D quantitative imaging analytics platform and services will be used to support Mediar’s Phase 2 EncompaSSc clinical trial. Qureight will evaluate changes in compartment-specific lung biomarkers in people with diffuse cutaneous Systemic Sclerosis (dcSSc) treated with MTX-474, a monoclonal antibody therapeutic.

Nuclera launches antibody triage service to advance AI-driven antibody discovery

● Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows ● Powered by cell-free technology to convert AI-generated candidates into experimental binding data

DNAstack and PhenoTips Partner to Deliver Sovereign Genomic Medicine Platform for Canadian Health Systems

Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure.

Sharma Lab Deploys Openwater’s Open-LIFU for Multidisciplinary Neurological Research at NC State and UNC

Teams from North Carolina State University and the University of North Carolina at Chapel Hill will study low-intensity focused ultrasound (LIFU) neuromodulation as a potential noninvasive approach for neurological and spinal cord conditions with Openwater's Open-LIFU.

NunaBio secures £6.5 million to scale next-generation DNA platform and advance infrastructure for synthetic biology

eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media

• Collaboration results in platform to help researchers overcome challenges in MSC research • NextCell-Cord RUO cells designed for delivery as cryopreserved and sold as an individual product or bundled with PRIME-XV media from FUJIFILM Biosciences

Patients benefit as the Royal Hospital for Neuro-disability introduces innovative predictive technology to support earlier recognition of infection risk